LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 146 filers reported holding LOXO ONCOLOGY INC in Q4 2017. The put-call ratio across all filers is 0.64 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $60,793,000 | -14.8% | 434,018 | +3.9% | 0.02% | 0.0% |
| Q3 2018 | $71,372,000 | +27.1% | 417,793 | +29.1% | 0.02% | +21.1% |
| Q2 2018 | $56,136,000 | +63.2% | 323,593 | +8.5% | 0.02% | +58.3% |
| Q1 2018 | $34,395,000 | +56.2% | 298,123 | +14.0% | 0.01% | +50.0% |
| Q4 2017 | $22,017,000 | +28.4% | 261,545 | +40.5% | 0.01% | +14.3% |
| Q3 2017 | $17,149,000 | – | 186,162 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 2,038,920 | $285,592,000 | 80.87% |
| DAFNA Capital Management LLC | 181,675 | $25,447,000 | 12.65% |
| Opaleye Management Inc. | 175,000 | $24,512,000 | 9.15% |
| Casdin Capital, LLC | 360,000 | $50,425,000 | 8.63% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 21,775 | $3,050,000 | 3.58% |
| Avoro Capital Advisors LLC | 325,000 | $45,523,000 | 2.72% |
| AWM Investment Company, Inc. | 70,000 | $9,805,000 | 2.13% |
| Opus Point Partners Management, LLC | 6,210 | $870,000 | 1.92% |
| Eventide Asset Management | 274,000 | $38,379,000 | 1.70% |
| Aquilo Capital Management, LLC | 24,750 | $3,467,000 | 1.68% |